איחוד האמירויות הערביות - אנגלית - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

alphamed drug store saudi arabia - 250ml bottle - inhalation - 250 ml - anaesthesia-general anaesthesia

אוסטרליה - אנגלית - APVMA (Australian Pesticides and Veterinary Medicines Authority)

shandong rainbow international co ltd - prothioconazole - unknown - prothioconazole triazole active 0.0 - active constituent

אוסטרליה - אנגלית - APVMA (Australian Pesticides and Veterinary Medicines Authority)

upl australia pty ltd - prothioconazole - unknown - prothioconazole triazole active 0.0 - active constituent

אוסטרליה - אנגלית - APVMA (Australian Pesticides and Veterinary Medicines Authority)

bayer cropscience pty ltd - prothioconazole - unknown - prothioconazole triazole active 0.0 - active constituent

ניו זילנד - אנגלית - Ministry for Primary Industries

agsin pte ltd - prothioconazole - prothioconazole 250 g/litre - fungicide

ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - atovaquone 250mg; proguanil hydrochloride 100mg - film coated tablet - active: atovaquone 250mg proguanil hydrochloride 100mg excipient: colloidal silicon dioxide hyprolose magnesium stearate microcrystalline cellulose opadry brown 03c86943 poloxamer sodium starch glycolate tolpovidone i 131 - promozio (250mg atovaquone/100mg proguanil hydrochloride) is indicated for: · prophylaxis of plasmodium falciparum malaria in adults · treatment of plasmodium falciparum malaria in adults.

ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - flucloxacillin sodium monohydrate 272.6mg equivalent to flucloxacillin 250 mg;   - capsule - 250 mg - active: flucloxacillin sodium monohydrate 272.6mg equivalent to flucloxacillin 250 mg   excipient: colloidal silicon dioxide gelatin magnesium stearate

ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

takeda new zealand limited - octocog alfa 250 [iu];   - injection with diluent - 250 iu - active: octocog alfa 250 [iu]   excipient: calcium chloride dihydrate glutathione histidine mannitol polysorbate 80 sodium chloride trehalose dihydrate trometamol water for injection - advate is indicated for use in haemophilia a for prevention and control of haemorrhagic episodes. patients with haemophilia a may be treated with advate as perioperative management. advate is not indicated in von willebrand's disease.

ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - nonacog alfa 250 [iu] (actual amount is 275 iu which includes 10% overage); nonacog alfa 250 [iu] (actual amount is 275 iu which includes 10% overage) - powder for injection with diluent - 250 iu - active: nonacog alfa 250 [iu] (actual amount is 275 iu which includes 10% overage) excipient: glycine histidine polysorbate 80 sucrose water for injection sodium chloride water for injection active: nonacog alfa 250 [iu] (actual amount is 275 iu which includes 10% overage) excipient: glycine histidine polysorbate 80 sucrose - for the control and prevention of haemorrhagic episodes in patients with haemophilia b (congenital factor ix deficiency or christmas disease), including control and prevention of bleeding in surgical settings.

ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

bayer new zealand limited - octocog alfa 250 [iu] - injection with diluent - 250 iu - active: octocog alfa 250 [iu] excipient: calcium chloride dihydrate glycine histidine polysorbate 80 sodium chloride sucrose water for injection water for injection - kogenate fs is indicated in congenital factor viii deficiency (haemophilia a) for the treatment and prophylaxis of bleeding in untreated and previously treated patients without inhibitors.